Treatment of choice in acute Bipolar disorder
**Core Concept**
Acute bipolar disorder requires immediate pharmacological intervention to stabilize mood and prevent further episodes. The primary goal is to rapidly control manic or depressive symptoms, ensuring patient safety and minimizing long-term consequences.
**Why the Correct Answer is Right**
The treatment of choice in acute bipolar disorder is lithium or, more commonly, antipsychotics with or without mood stabilizers. **Lithium** is a mood stabilizer that helps regulate neurotransmitter activity, particularly the reduction of norepinephrine and serotonin reuptake. **Antipsychotics**, such as olanzapine or risperidone, can rapidly control manic symptoms by blocking dopamine receptors in the mesolimbic pathway. The combination of an antipsychotic with a mood stabilizer like lithium or valproate provides a synergistic effect, ensuring more effective symptom management.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because benzodiazepines, such as alprazolam, may provide temporary anxiolytic effects but do not address the underlying mood dysregulation in bipolar disorder.
**Option B:** This option is incorrect because antidepressants, such as selective serotonin reuptake inhibitors (SSRIs), can potentially trigger manic episodes or destabilize mood in bipolar patients.
**Option C:** This option is incorrect because electroconvulsive therapy (ECT) is typically reserved for treatment-resistant cases or severe, acute depressive episodes, not the initial management of acute bipolar disorder.
**Clinical Pearl / High-Yield Fact**
When initiating treatment for acute bipolar disorder, it's essential to consider the patient's history of response to previous medications, potential side effects, and the risk of medication interactions or adverse effects.
**Correct Answer: C. Antipsychotics with or without mood stabilizers**